Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma.
Fritchie KJ, Ameline B, Andrei V, Griffith C, Shah AA, Dermawan JK, Trucco M, Budd T, Thangaiah JJ, Molligan J, Whaley RD, Magliocca K, Azzato E, van Zante A, Jo V, Xu B, Bishop JA, Rooper L, Baumhoer D. Fritchie KJ, et al. Among authors: magliocca k. Mod Pathol. 2023 Nov;36(11):100301. doi: 10.1016/j.modpat.2023.100301. Epub 2023 Aug 9. Mod Pathol. 2023. PMID: 37567448
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology.
Gupta R, Bal M, Bishop JA, Hunter KD, Magliocca K, Seethala RR, Thompson LDR, Weinreb I, Angelos P, Beadle B, Bell RB, Clark JR, Ferris R, Huang SH, Hayes DN, Ladwa R, Yang J, Cipriani NA, Nelson BL, Sadow PM, Lewis JS. Gupta R, et al. Among authors: magliocca k. Head Neck Pathol. 2023 Sep;17(3):877-880. doi: 10.1007/s12105-023-01570-w. Epub 2023 Jul 24. Head Neck Pathol. 2023. PMID: 37486534 No abstract available.
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Xu B, Viswanathan K, Ahadi MS, Ahmadi S, Alzumaili B, Bani MA, Baudin E, Behrman DB, Capelletti M, Chau NG, Chiarucci F, Chou A, Clifton-Bligh R, Coluccelli S, de Biase D, De Leo A, Dogan S, Fagin JA, Fuchs TL, Glover AR, Hadoux J, Lacroix L, Lamartina L, Lubin DJ, Luxford C, Magliocca K, Maloberti T, Mohanty AS, Najdawi F, Nigam A, Papachristos AJ, Repaci A, Robinson B, Scoazec JY, Shi Q, Sidhu S, Solaroli E, Sywak M, Tuttle RM, Untch B, Barletta JA, Al Ghuzlan A, Gill AJ, Ghossein R, Tallini G, Ganly I. Xu B, et al. Among authors: magliocca k. Thyroid. 2024 Feb;34(2):167-176. doi: 10.1089/thy.2023.0279. Epub 2023 Nov 7. Thyroid. 2024. PMID: 37842841
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.
Nadeem S, Hanna MG, Viswanathan K, Marino J, Ahadi M, Alzumaili B, Bani MA, Chiarucci F, Chou A, De Leo A, Fuchs TL, Lubin DJ, Luxford C, Magliocca K, Martinez G, Shi Q, Sidhu S, Al Ghuzlan A, Gill AJ, Tallini G, Ghossein R, Xu B. Nadeem S, et al. Among authors: magliocca k. Histopathology. 2023 Dec;83(6):981-988. doi: 10.1111/his.15048. Epub 2023 Sep 14. Histopathology. 2023. PMID: 37706239
Targeted therapies in ameloblastomas and amelobastic carcinoma-A systematic review.
Bologna-Molina R, Schuch L, Magliocca K, van Heerden W, Robinson L, Bilodeau EA, Hussaini HM, Soluk-Tekkesin M, Adisa AO, Tilakaratne WM, Li J, Gomez RS, Hunter KD. Bologna-Molina R, et al. Among authors: magliocca k. Oral Dis. 2024 May 1. doi: 10.1111/odi.14962. Online ahead of print. Oral Dis. 2024. PMID: 38693620 Review.
Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience.
Lengyel K, Lubin DJ, Hsiao WY, Sirotnikov S, Luo G, Roberts JW, Shi Q, Magliocca K, Lewis MM, Sears DL, Ilyas G, Rogers BB, Viswanathan K. Lengyel K, et al. Among authors: magliocca k. Cancer Cytopathol. 2024 Jun;132(6):359-369. doi: 10.1002/cncy.22805. Epub 2024 Mar 23. Cancer Cytopathol. 2024. PMID: 38520219
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Aksoy YA, Xu B, Viswanathan K, Ahadi MS, Al Ghuzlan A, Alzumaili B, Bani MA, Barletta JA, Chau N, Chou A, Clarkson A, Clifton-Bligh RJ, De Leo A, Dogan S, Ganly I, Ghossein R, Gild ML, Glover AR, Hadoux J, Lamartina L, Lubin DJ, Magliocca K, Najdawi F, Nigam A, Papachristos A, Repaci A, Robinson BG, Sheen A, Shi Q, Sidhu SB, Sioson L, Solaroli E, Sywak MS, Tallini G, Tsang V, Turchini J, Untch BR, Gill AJ, Fuchs TL. Aksoy YA, et al. Among authors: magliocca k. Histopathology. 2024 May;84(6):947-959. doi: 10.1111/his.15141. Epub 2024 Jan 22. Histopathology. 2024. PMID: 38253940
153 results